07.04.2020

Our experts and team will help even in a state of emergency

We also want to help secure the operations of our customers.

28.03.2020

Many new experts join DRA – our international expertise is increasing further

Welcome to join us Sari, Jonna, Stina and Jussi!

17.03.2020

Information on the effects of Covid-19 on DRA’s business

Our team of experts is highly committed to support you during this difficult time as well as possible.

01.03.2020

Patients have a voice – Five highlights from the Eupati Nordic Workshop

In future, patient involvement and the patients’ “voice” will have an increasingly important role.

04.02.2020

Great results from our client satisfaction survey

We were particularly thanked for service-mindedness and meeting the agreed timelines as well as for co-operation fostering our clients’ business goals.

10.01.2020

Returnee strengthens the DRA team

DRA has also been joined by a “returnee”, Eija Kinos.

16.12.2019

DRA Consulting Oy wants to help fight the climate change

This year we made a donation to the Finnish Association for Nature Conservation in their climate protection work.

12.11.2019

ISPOR Europe: More transborder co-operation between the authorities is needed in medicines evaluation and health technology assessment

Co-operation can produce high-quality and topical scientific reports, transparent processes and clear requirements for the evidence required.

25.10.2019

Meet us at #ISPOREurope

Join us in Copenhagen on 2-6 November 2019! Drop by booth #C2-011 and have a chat with us.

17.10.2019

TOPRA 2019: Technology poses challenges to the regulatory world – patient involvement is pursued

Is Europe prepared to assess medicines based on new technologies or novel innovations, or different types of study data?

20.09.2019

TOPRA is approaching – See you there!

Meet us at the TOPRA Annual Symposium on 30 September – 2 October 2019 in Dublin, Ireland.

15.08.2019

New EMA guidance on management of medicine shortages

EMA has published guidance to marketing authorisation holders and authorities to improve and harmonise management of medicine shortages and related reporting and communication.

1 2 3 12